Range Impact Inc. Files S-1/A Amendment

Ticker: RNGE · Form: S-1/A · Filed: Dec 4, 2024 · CIK: 1438943

Range Impact, Inc. S-1/A Filing Summary
FieldDetail
CompanyRange Impact, Inc. (RNGE)
Form TypeS-1/A
Filed DateDec 4, 2024
Risk Levelmedium
Pages14
Reading Time17 min
Key Dollar Amounts$0.001, $0.2135
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, ipo, registration-statement

TL;DR

Range Impact (fka Malachite/Vitality/Stevia) filed S-1/A. Public offering incoming.

AI Summary

Range Impact, Inc. filed an S-1/A amendment on December 4, 2024, for its registration statement. The company, formerly known as Malachite Innovations, Inc., Vitality Biopharma, Inc., and Stevia First Corp., is incorporated in Nevada and headquartered in Cleveland, Ohio. The filing is related to the Securities Act of 1933.

Why It Matters

This S-1/A filing indicates Range Impact, Inc. is moving forward with its public offering plans, which could impact its stock and the broader construction sector.

Risk Assessment

Risk Level: medium — S-1/A filings are typically associated with initial public offerings or significant corporate changes, which inherently carry market and execution risks.

Key Numbers

  • 333-279203 — SEC File Number (Identifies the specific registration filing with the SEC.)
  • 20241204 — Filing Date (The date the amendment was filed with the SEC.)

Key Players & Entities

  • RANGE IMPACT, INC. (company) — Registrant
  • Malachite Innovations, Inc. (company) — Former Company Name
  • Vitality Biopharma, Inc. (company) — Former Company Name
  • Stevia First Corp. (company) — Former Company Name
  • Michael Cavanaugh (person) — Chief Executive Officer
  • 200 Park Avenue, Suite 400 Cleveland, Ohio 44122 (location) — Principal Executive Offices

FAQ

What is the primary purpose of this S-1/A filing for Range Impact, Inc.?

This S-1/A filing is an amendment to a registration statement under the Securities Act of 1933, indicating the company is updating or supplementing information related to a potential public offering or other securities transaction.

What were Range Impact, Inc.'s previous names?

Range Impact, Inc. was formerly known as Malachite Innovations, Inc., Vitality Biopharma, Inc., and Stevia First Corp.

Who is the Chief Executive Officer of Range Impact, Inc.?

Michael Cavanaugh is the Chief Executive Officer of Range Impact, Inc.

Where are Range Impact, Inc.'s principal executive offices located?

The principal executive offices of Range Impact, Inc. are located at 200 Park Avenue, Suite 400, Cleveland, Ohio 44122.

What is the SIC code for Range Impact, Inc.?

The Standard Industrial Classification (SIC) code for Range Impact, Inc. is 1600, which corresponds to Heavy Construction Other Than Building Construction - Contractors.

Filing Stats: 4,324 words · 17 min read · ~14 pages · Grade level 18.4 · Accepted 2024-12-04 09:00:51

Key Financial Figures

  • $0.001 — ”) of our Common Stock, par value $0.001 per share (“Common Stock”),
  • $0.2135 — rted sale price of our Common Stock was $0.2135. Investing in our securities involves

Filing Documents

RISK FACTORS

RISK FACTORS 10 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 18

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 20

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 21 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 22

USE OF PROCEEDS

USE OF PROCEEDS 23 DIVIDEND POLICY 24 DETERMINATION OF OFFERING PRICE 24 SELLING STOCKHOLDERS 25 PLAN OF DISTRIBUTION 27

DESCRIPTION OF SECURITIES TO BE REGISTERED

DESCRIPTION OF SECURITIES TO BE REGISTERED 28 LEGAL MATTERS 31 EXPERTS 31 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 31 INFORMATION NOT REQUIRED IN PROSPECTUS 32

SIGNATURES

SIGNATURES 36 i ABOUT THIS PROSPECTUS You should rely only on the information we have provided or incorporated by reference in this prospectus, any applicable prospectus supplement and any related free writing prospectus. We have not authorized anyone to provide you with information different from that contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. You must not rely on any unauthorized information or representation. This prospectus is an offer to sell only the Shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should assume that the information in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate only as of the date on the front of the document, regardless of the time of delivery of this prospectus or any sale of a security. The Selling Stockholders are offering the Shares only in jurisdictions where such issuances are permitted. The distribution of this prospectus and the issuance of the Shares in certain jurisdictions may be restricted by law. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the issuance of the Shares and the distribution of this prospectus outside the United States. This prospectus does not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, the Shares offered by this prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation. This prospectus is part of a registration statement that we filed with the SEC, under which the Selling Stockholders m

Business

Business We are a public company dedicated to improving the health and wellness of people and the planet through a novel and innovative approach to impact investing. We own and operate several complementary operating businesses focused on developing long-term solutions to environmental, social, and health challenges, with a particular focus on acquiring, reclaiming and repurposing mine sites and other undervalued land in economically disadvantaged communities throughout Appalachia. We take an opportunistic approach to impact investing by leveraging our competitive advantages and looking at solving old problems in new ways. We seek to thoughtfully allocate our capital into strategic opportunities that are expected to make a positive impact on the people-planet ecosystem and generate strong investment returns for our shareholders. Impact Investing Strategy Our impact investing strategy aims to improve the health and wellness of people and the planet, while also generating long-term sustainable financial returns for our shareholders. We believe that doing well and doing good are not mutually exclusive, and that an impact investing strategy can balance the environmental, social and economic needs of people and the planet while also generating attractive risk-adjusted financial returns for shareholders. Our impact investing strategy provides an opportunity for our dedicated team to address pressing environmental, social and economic challenges, such as air and water pollution, educational inequality and economic disparity, and climate change, through the development of technology-based solutions. By actively directing investment capital towards businesses that are working to create positive environmental, social and economic outcomes, we believe that our impact investing strategy can contribute to an improved people-planet ecosystem and a healthier and happier way of life. 5 We have a particular interest in providing environmental and social solutions in econ

View Full Filing

View this S-1/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.